Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Transplantation Proceedings|January 11, 2024
Efficacy and Reliability of T-Cell-Depleted Haploidentical Stem Cell Transplantation in Hematologic Disorders: A Retrospective StudyBurak Deveci, George Kublashvili, Ayse Tuba Oztekin, et al.Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|February 7, 2025
Long-Term Outcomes of Allogeneic Stem Cell Transplantation for Relapsed/Refractory Hodgkin and Non-Hodgkin Lymphoma: Multi-center Experience from TurkeyAyse Uysal, Nur Akad Soyer, Hakan Ozdogu, et al.Annals of Hematology|April 17, 2023
Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantationMuzaffer Keklik, Burak Deveci, Serhat Celik, et al.Leukemia Research|April 25, 2016
Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter studyOzan Salim, Tayfur Toptas, Esin Avsar, et al.Journal of Clinical Medicine|July 15, 2026
Direct Second Autologous Stem Cell Transplantation Versus Re-Induction Followed by Transplantation in Relapsed Multiple Myeloma: A Multicenter Real-World StudyTaha Ulutan Kars, Hakan Göker, Haluk Demiroğlu, et al.Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|May 31, 2021
Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria with or without Aplastic Anemia: A Multicenter Turkish ExperienceFergün Yılmaz, Nur Soyer, Güldane Cengiz Seval, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 12, 2020
Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of Turkish hematology research and education group (ThREG)Nur Soyer, Mehmet Gunduz, Emre Tekgunduz, et al.Annals of Hematology|November 19, 2022
Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from TurkeyMehmet Sinan Dal, Bahar Uncu Ulu, Ant Uzay, et al.Journal of Clinical Medicine|October 29, 2025
Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and MicafunginUnal Atas, Utku Iltar, Orhan Kemal Yucel, et al.Hematological Oncology|May 22, 2023
Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world dataElif Birtas Atesoglu, Zafer Gulbas, Ant Uzay, et al.Pageof 3